In the article by Broderick et al (Broderick JP, Berkhemer OA, Palesch YY, Dippel DWJ, Foster LD, Roos YBWEM, van der Lugt A, Tomsick TA, Majoie CBLM, van Zwam WH, Demchuk AM, van Oostenbrugge RJ, Khatri P, Lingsma HF, Hill MD, Roozenbeek B, Jauch EC, Jovin TG, Yan B, von Kummer R, Molina CA, Goyal M, Schonewille WJ, Mazighi M, Engelter ST, Anderson CS, Spilker J, Carrozzella J, Ryckborst KJ, Janis LS, Simpson KN; IMS III and MR CLEAN Investigators. Endovascular therapy is effective and safe for patients with severe ischemic stroke: pooled analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands Data. Stroke. 2015;46:3416–3422. DOI: 10.1161/STROKEAHA.115.011397.), which published online ahead of print on October 20, 2015, and appeared in the December 2015 issue of the journal, a correction was needed.
On page 3416, in the author byline, “IMS II,” has been changed to read “IMS III” investigators.
The publisher regrets the error.
This correction has been made to the online version of the article, which is available at http://stroke.ahajournals.org/content/46/12/3416.
- © 2015 American Heart Association, Inc.